Bioactivity:

Tazemetostat is an orally available, small molecule selective and S-adenosyl methionine (SAM) competitive inhibitor of histone methyltransferase EZH2, with potential antineoplastic activity. Upon oral administration, Tazemetostat selectively inhibits the

CAS nr:

1403254-99-8

Purity:

98%

Molecular Weight:

572,74

SMILES:

CCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)-c1ccc(CN2CCOCC2)cc1

Formula:

C34H44N4O4

Pathway:

Chromatin/Epigenetic

Target:

Histone Methyltransferase